3D Bioprinting Market Set to Surge to USD 6.82 Billion by 2034 at a 11.8% of CAGR

The global 3D bioprinting market is on a strong growth trajectory, with an anticipated market valuation of USD 2.24 billion by 2024. Looking ahead, the market is projected to surge to USD 6.82 billion by 2034, driven by a robust Compound Annual Growth Rate (CAGR) of 11.8% from 2024 to 2034.

This remarkable growth is fueled by significant advancements in tissue engineering and regenerative medicine. The market’s expansion is further supported by increased collaborations between research institutions, biotech companies, and healthcare providers, alongside rising investments in bioprinting technology.

3D bioprinting, which involves creating complex tissue structures and organs using biocompatible materials, is revolutionizing the field of personalized medicine. The technology’s ability to customize treatments and improve patient outcomes is driving its adoption across various medical and research applications.

Request a report – sample

Key Takeaways

• The 3D cell culture method is an effective alternative to overcome the existing organ donation shortage crisis faced by the world. According to the U.S. Government Information on Organ Donation and Transplantation, more than 113,000 people are on the waiting list as of July 2019. The unavailability of organs for transplant cause the death of 20 patients per day.
• 3D bioprinting can be a significant solution to the organ transplant waiting for crisis so that patients can receive an organ for transplant in time. 3D bioprinting technology has been used in regenerative medicine through printed devices such as 3D printing surgical instruments and prosthetics. Currently, researchers are testing out bio-ink as a way of printing cartilage, bones, and vital organs.
• The ongoing research on regenerative medicine and advancements in tissue engineering are focusing on the regeneration of damaged tissues and organs with the help of 3D bioprinting. A group of scientists from Tel Aviv University developed a fully vascularized heart using 3D bioprinting by using fat tissue cells from a donor. This has led to the development of 3D bio-printed heart tissue. Scientists from Swansea University UK developed a 3D bioprinting process by using regenerative and durable biomaterial.

Customization Available – Here

Competitive Landscape

The key players operating in the 3D bioprinting market are currently strengthening their materials portfolio. This is mainly done by adding new metals to the product portfolio. Apart from that, technological upgradation is also being done by the key players to simplify the processes. 3D Systems, GE Healthcare, ExOne, Electro Optical Systems, Renishaw plc, and others are the top player of the 3D bioprinting market.

More Insights into the 3D bioprinting market

The Asia Pacific region is expected to dominate the global 3D bioprinting market over the assessment period. As per FMI analysis, developing economies like India, China, and Japan are expected to make massive contributions, owing to massive investment in the healthcare sector. Additionally, increasing disposable income is also expected to surge the market share in this region.

China is expected to generate reasonable revenue in the global market since the Chinese government is offering to fund the establishment of a manufacturing facility for the production of biomaterials and studying 3D-printed organs and tissues. In 2015, Materialise NV. opened its first pediatric 3D medical research facility at the Children’s Medical Center, in Shanghai, China. The focus was on pediatric 3D modeling and medical imaging and 3D fabrication.

3D Bioprinting Market Segmentation

By Technology:

• Stereolithography
• Selective Laser Sintering
• Electron Beam Melting
• Fused Deposition Modeling
• Laminated Object Manufacturing
• Inkjet Printing
• Multi-phase Jet Solidification

By Application:

• Surgical Simulation and Training Models
• Prosthetic Devices
• Tissue Engineering and Regenerative Medicine
• Orthopedic Implants
• Dental Implants
• Medical Sensors
• Others

By End User:

• Medical Device Manufacturers
• Pharmaceutical Companies
• Research & Academic Institutions
• Contract Research Organizations

By Region:

• North America
• Latin America
• Europe
• East Asia
• South Asia
• Oceania
• MEA

Obtain Extensive Market Insights – Purchase Now to Access

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:         

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube